IRCT20200127046282N27
Recruiting
Phase 1
Study of safety and effectiveness of mesenchymal stem cells condition medium and 665nm low level diode laser hat in the treatment of androgenetic alopecia
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Androgenetic alopecia Type 2\-4
- •Do not take topical or oral medication to treat alopecia in the last six months
Exclusion Criteria
- •Age under 18 years
- •Breastfeeding
- •History of malignant diseases
- •Take any topical or systemic treatment during the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Evaluation of the safety and effectiveness of mesenchymal stem cells conditioned medium in the treatment of hair lossHair loss.Nonscarring hair loss, unspecifiedL65.9IRCT20200127046282N13Tehran University of Medical Sciences45
Completed
Not Applicable
Effects of mesenchymal stem cells therapy in peritoneal dialysis patientsChronic kidney disease.Chronic kidney disease, stage 5IRCT2015052415841N2Vice chancellor for research, Tehran University of Medical Sciences10
Completed
Phase 1
Mesenchymal Stromal Cells to Treat Steroid-refractory Graft Versus Host Disease after Bone Marrow TransplantatioGraft Versus Host DiseaseInflammatory and Immune System - Other inflammatory or immune system disordersBlood - Haematological diseasesACTRN12610000068066R.P.Herrmann20
Not yet recruiting
Not Applicable
Safety and Efficacy of MCA-derived Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients: The Nereid Study*BPARrejection transplanted kidney10038430NL-OMON53310eids Universitair Medisch Centrum16
Completed
Not Applicable
To investigate the efficacy of mesenchymal stem cell conditioned media (MSCs-CM) on ameliorate maturation and developmental potential of immature human oocytes after artificial activation in the infertile female.IRCT2017101736840N1Vice Chancellor for Research, Kerman University of Medical Sciences100